Horizon Therapeutics plc to Release Third-Quarter 2020 Financial Results and Host Webcast on Nov. 2, 2020Business Wire • 10/08/20
Horizon Therapeutics plc Named One of San Francisco Bay Area’s Best and Brightest Companies to Work ForBusiness Wire • 10/07/20
Horizon Therapeutics: SEL-212 Data Confirms Krystexxa's Likely Dominant Position In Refractory GoutSeeking Alpha • 10/06/20
Horizon Therapeutics plc Announces TEPEZZA® (teprotumumab-trbw) Selected as a Winner of the R&D 100 AwardBusiness Wire • 10/05/20
Horizon Therapeutics plc Named as an Angels in Adoption® Honoree by U.S. Congressional Coalition on Adoption for #RAREis Adoption Fund partnership with Gift of AdoptionBusiness Wire • 10/01/20
Horizon Therapeutics Stock Hits Record High As Sales Of Key Drug Top ViewsInvestors Business Daily • 09/23/20
Is Horizon Therapeutics Public Limited (HZNP) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 09/18/20
MIRROR Open-Label Trial Data Published in Journal of Rheumatology Show 79 Percent of Patients Achieved a Complete Response Using KRYSTEXXA® (pegloticase injection) with MethotrexateBusiness Wire • 09/16/20
Jefferies Top Growth Stocks to Buy Include 4 Red-Hot Health Care Companies24/7 Wall Street • 09/15/20
Horizon Therapeutics plc Named to the 2020 PEOPLE “50 Companies That Care” ListBusiness Wire • 09/02/20
Horizon Therapeutics plc to Present at the Morgan Stanley 18th Annual Global Healthcare ConferenceBusiness Wire • 09/01/20
Horizon Therapeutics plc Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Ordinary SharesBusiness Wire • 08/11/20
Horizon Therapeutics Named one of the Best Places to Work in Chicago by Crain’s Chicago BusinessBusiness Wire • 08/10/20
Horizon Therapeutics (HZNP) Looks Good: Stock Adds 5.3% in SessionZacks Investment Research • 08/10/20
Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary SharesBusiness Wire • 08/07/20